Happy days ahead so we hope. My confidence level
Post# of 72440
I did cringe a bit with the issues to Aspire. I would love to see a partnership come through in the next month or so (by the end of September). I'm not a fan of dilution, especially the way they went about it. Of course it would be less shares if this was around $2 - $4.
Imagine going it alone and striking an offering of $30 - $60 MILLION when we're well under the $. That would be nuts. But, companies do it all the time. And the market absorbs the dilution if the drug is potentially worth it. We have 3 that are potentially worth it.
Looking forward to getting out of this rut and moving up. Science wins. Good data continues, we'll get there. Great data, great 1st partnership, life changing. Being patient.
Uplisting and moving the science forward will leave many in the dust.
IMO